Antibodies to oncostatin M receptor
US8216578B2 · kind B2 · utility
18Cited by
26References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 2009 |
| Grant date | Jul 10, 2012 |
| Priority date | — |
| Expiry date | Mar 22, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/715
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention provides characterization of the disease and cancer-associated antigen, OSM-R.beta. The invention also provides modulators of OSM-R.beta, including a family of monoclonal antibodies that bind to antigen OSM-R.beta, and methods of diagnosing and treating various human cancers and diseases associated with OSM-R.beta.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.